Zoetis (ZTS)
(Delayed Data from NYSE)
$180.76 USD
+1.10 (0.61%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $180.75 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
Brokerage Reports
Zoetis Inc. [ZTS]
Reports for Purchase
Showing records 181 - 200 ( 256 total )
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Sector Analysis Update: Clinical News Drives Vet Biotech Stock Performance
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
On January 12, 2016, Zoetis provided an update on the company?s tax outlook for 2016 and 2017 following the European Commission?s decision to reverse certain Belgium tax benefits.
Provider: G.RESEARCH, LLC
Analyst: KEDRA K